The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- More Than Crew Room Politics. Our Careers Are on the Line.
- Illinois SLD Bob Guy Takes the Fight for Rail Safety to a National Audience
- 25 Years Ago, We Promised to Never Forget. Today, We Must Refuse to Look Away.
- NTSB and FRA Put Shove Move Safety in National Spotlight
- DIPP Announces Assessment and Benefit Coverage Changes
- Fighting the Digital Tripwire: SMART-TD Sounds the Alarm on AI Surveillance
- One Union, One Fight: SMART-TD Takes Rail, Bus and Transit to Capitol Hill
- A Perfect Score for Solidarity at Annual Carolina Shootout
- A Homecoming in Charlotte: SMART-TD Leadership Tours CATS Bus Yard and Mechanical Facilities
- RRB Issues Scam Notice: What You Need to Know